Mesa Laboratories Inc

MLAB

Mesa Laboratories Inc (MLAB) is a global provider of specialized analytical and monitoring instrumentation, primarily serving the healthcare, pharmaceutical, and biotechnology industries. The company develops and manufactures products for sterilization validation, environmental monitoring, and other quality assurance processes, focusing on ensuring safety and compliance in critical environments.

$97.94 -1.50 (-1.51%)
Dividend Yield 0.65%
Payout Frequency Quarterly

Dividend History

🎉 Upcoming Dividend

Investors can expect a dividend payout of $0.16 per share, scheduled to be distributed in 59 days on September 15, 2026

Pay DateAmountEx-DateRecord Date
September 15, 2026$0.162026-08-312026-08-31
June 15, 2026$0.162026-05-292026-05-29
March 16, 2026$0.162026-02-272026-02-28
December 15, 2025$0.162025-11-282025-11-28
September 15, 2025$0.162025-08-292025-08-29

Dividends Summary

Company News

Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today
The Motley Fool • Keith Noonan • May 27, 2026

Mesa Laboratories stock plummeted 19.5% on May 27, 2026, after reporting Q4 fiscal 2026 results. While the company beat expectations on adjusted operating income per share ($3.30 vs. $1.54 estimate), sales of $63.72 million fell short of Wall Street expectations by approximately $1.48 million. CEO Siddhartha Kadia is conducting an internal review...

MESA LABS DECLARES QUARTERLY DIVIDEND
GlobeNewswire Inc. • Mesa Laboratories, Inc. • July 3, 2025

Mesa Laboratories announced a quarterly dividend of $0.16 per share, payable on September 15, 2025, to shareholders of record as of August 29, 2025.

MESA LABS DECLARES QUARTERLY DIVIDEND
GlobeNewswire Inc. • N/A • April 7, 2025

Mesa Laboratories, Inc. (MLAB) announced a regular quarterly dividend of $0.16 per share, payable on June 16, 2025. The company is a global leader in life science tools and quality control solutions for the pharmaceutical, healthcare, and medical device industries.

Mesa Labs Announces Second Quarter Results
GlobeNewswire Inc. • N/A • November 7, 2024

Mesa Laboratories, Inc. reported its second quarter fiscal year 2025 results, with revenues increasing 8.8% year-over-year. The company's Biopharmaceutical Development and Calibration Solutions divisions saw strong growth, while the Clinical Genomics division faced headwinds in China and North America.

MESA LABS DECLARES QUARTERLY DIVIDEND
GlobeNewswire Inc. • N/A • October 2, 2024

Mesa Laboratories, Inc. (NASDAQ:MLAB) announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock, payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024.

Related Companies